Article citationsMore>>

Centocor, I. (2012) A Phase II, Double-Blind, Placebo-Controlled, Randomized, Dose-Ranging Study of Multiple Subcutaneous Injections of Human Monoclonal Antibody to IL-12 p40 (CNTO1275) in Subjects with Relapsing-Remitting Multiple Sclerosis. NCT00207727.

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top